Pfizer and Valneva said on Monday their Lyme disease vaccine showed more than 70% efficacy in a late-stage study, even as it missed its main goal
Pfizer and Valneva said on Monday their Lyme disease vaccine showed more than 70% efficacy in a late-stage study, even as it missed its main goal.
U.S.-listed shares of the French drugmaker tumbled more than 35% in premarket trading following the upd... [1402 chars]